إعلان
إعلان

XTNT

XTNT logo

Xtant Medical Holdings, Inc.

0.69
USD
برعاية
-0.01
-1.97%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

0.71

+0.02
+3.21%

تقارير أرباح XTNT

النسبة الإيجابية المفاجئة

XTNT تفوق 13 من 28 آخر التقديرات.

46%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$31.36M
/
$0.00
التغير الضمني من Q3 25 (Revenue/ EPS)
-5.68%
/
-100.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-0.47%
/
-100.00%

Xtant Medical Holdings, Inc. earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, XTNT reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 296.08% surprise. Revenue reached 33.26 مليون, compared to an expected 33.35 مليون, with a -0.30% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.00 USD, with revenue projected to reach 31.36 مليون USD, implying an نقصان of -100.00% EPS, and نقصان of -5.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Xtant Medical Holdings, Inc. reported EPS of $0.01, beating estimates by 296.08%, and revenue of $33.26M, -0.3% below expectations.
The stock price moved down -0.62%, changed from $0.76 before the earnings release to $0.76 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 4 المحللين, Xtant Medical Holdings, Inc. is expected to report EPS of -- and revenue of $31.36M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان